A Bifunctional Small Molecule Degrader of the Long Noncoding RNA MALAT1 Triplex

Area of Science:

• Molecular Biology
• RNA Therapeutics
• Medicinal Chemistry

Background:

• Aberrant RNA regulation is implicated in various diseases.
• Long noncoding RNAs (lncRNAs), such as MALAT1, play roles in disease processes, including metastasis.
• Targeted degradation of specific lncRNAs presents a potential therapeutic strategy.

Purpose of the Study:

• To introduce a novel small molecule, PINAD-1, for targeted RNA degradation.
• To investigate the mechanism of selective degradation of the MALAT1 lncRNA.
• To explore the potential of bifunctional small molecules for RNA-based therapeutics.

Main Methods:

• Design and synthesis of PINAD-1, a conjugate of a MALAT1-specific binder and an RNA-degrading warhead.
• In vitro and in cellulo assays to assess RNA degradation activity.
• Mechanistic studies to elucidate the requirements for effective RNA degradation, including structural context and binder-induced destabilization.

Main Results:

• PINAD-1 selectively induces the degradation of the MALAT1 lncRNA.
• Minimal off-target degradation was observed on the structurally similar NEAT1 lncRNA.
• Effective RNA degradation depends on specific structural context and binder-induced destabilization, not just proximity.

Conclusions:

• PINAD-1 is a first-in-class small molecule enabling targeted degradation of MALAT1.
• The findings highlight the importance of RNA structure and binder interactions in designing RNA degraders.
• This work provides a foundation for developing bifunctional small-molecule RNA degraders for therapeutic applications targeting structured noncoding RNAs.